NASDAQ: PDEXPro Dex Inc Stock
$58.26-1.76 (-2.93%)
Updated Oct 16, 2026
PDEX Price
$58.26
Fair Value Price
$86.94
Market Cap
$186.63M
52 Week Low
$25.25
52 Week High
$77.00
P/E
13.74x
P/B
3.92x
P/S
2.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$77.55M
Earnings
$13.66M
Gross Margin
31.4%
Operating Margin
24.28%
Profit Margin
17.6%
Debt to Equity
0.56
Operating Cash Flow
$7M
Beta
0.59
Next Earnings
Oct 29, 2026
Ex-Dividend
N/A
Next Dividend
N/A
PDEX Overview
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PDEX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
PDEX
Ranked#5 of 40
Ranked#5 of 40
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $118.28 | A | |
| $162.99 | A | |
| $13.40 | A |
Be the first to know about important PDEX news, forecast changes, insider trades & much more!
PDEX News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PDEX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PDEX ($58.26) is undervalued by 32.99% relative to our estimate of its Fair Value price of $86.94 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PDEX ($58.26) is significantly undervalued by 32.99% relative to our estimate of its Fair Value price of $86.94 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PDEX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PDEX due diligence checks available for Premium users.
Valuation
PDEX fair value
Fair Value of PDEX stock based on Discounted Cash Flow (DCF)
Price
$58.26
Fair Value
$86.94
Undervalued by
32.99%
PDEX ($58.26) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PDEX ($58.26) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PDEX is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PDEX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.74x
Industry
44.47x
Market
42.68x
PDEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PDEX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PDEX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.92x
Industry
3.42x
PDEX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PDEX's financial health
Profit margin
Revenue
$20.4M
Net Income
$2.9M
Profit Margin
14%
PDEX's Earnings (EBIT) of $18.83M... subscribe to Premium to read more.
Interest Coverage Financials
PDEX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$74.5M
Liabilities
$26.9M
Debt to equity
0.56
PDEX's short-term assets ($53.25M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PDEX's short-term assets ($53.25M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PDEX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PDEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$273.0k
Investing
$198.0k
Financing
-$1.7M
PDEX's operating cash flow ($7.24M)... subscribe to Premium to read more.
Debt Coverage Financials
PDEX vs Medical Stocks
Pro Dex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.